title: An incidental finding.
abstract: Pruritic patches on the patient's trunk and extremities prompted his visit, but it was the "birthmark" on his back that was far more worrisome.
authors.affiliation: Primary Care Services, VA Medical Center, Martinsburg, WV, USA. Email: suresh10suresh@msn.com.
authors.forename: Suresh K
authors.initials: SK
authors.lastname: Menon
mesh_terms: D000328:Adult; D000911:Antibodies, Monoclonal / Q000627:therapeutic use; D000970:Antineoplastic Agents / Q000627:therapeutic use; D001415:Back; D001706:Biopsy / Q000379:methods; D060908:CTLA-4 Antigen / Q000037:antagonists & inhibitors; D003937:Diagnosis, Differential; D006801:Humans; D033162:Incidental Findings; D007211:Indoles / Q000627:therapeutic use; D000074324:Ipilimumab; D008297:Male; D008545:Melanoma / Q000235:genetics / Q000401:mortality / Q000473:pathology* / Q000628:therapy; D009362:Neoplasm Metastasis; D011379:Prognosis; D048493:Proto-Oncogene Proteins B-raf / Q000037:antagonists & inhibitors / Q000235:genetics; D012867:Skin / Q000473:pathology; D012878:Skin Neoplasms / Q000235:genetics / Q000401:mortality / Q000473:pathology* / Q000628:therapy; D013449:Sulfonamides / Q000627:therapeutic use; D000077484:Vemurafenib
chemical_list: D000911:Antibodies, Monoclonal; D000970:Antineoplastic Agents; D060908:CTLA-4 Antigen; C556706:CTLA4 protein, human; D007211:Indoles; D000074324:Ipilimumab; D013449:Sulfonamides; D000077484:Vemurafenib; D048493:Proto-Oncogene Proteins B-raf